Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada

NCT00334750 · clinicaltrials.gov ↗

COMPLETED

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

OTHER: There is no intervention in this study.

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.